Safety and Immunogenicity of NVX-CoV2705
Public ClinicalTrials.gov record NCT07079670. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Open-Label, Single-Arm Study to Evaluate the Safety and Immunogenicity of an Omicron JN.1 Subvariant SARS-CoV-2 rS Vaccine Adjuvanted With Matrix-M
Study identification
- NCT ID
- NCT07079670
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 676 participants
Conditions and interventions
Conditions
Interventions
- NVX-CoV2705 Biological
Biological
Eligibility (public fields only)
- Age range
- 12 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 8, 2025
- Primary completion
- Jan 11, 2026
- Completion
- May 10, 2026
- Last update posted
- Jun 4, 2026
2025 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number US404 | Phoenix | Arizona | 85044 | — |
| Investigational Site Number US395 | Melrose Park | Illinois | 60160 | — |
| Investigational Site Number US406 | Lenexa | Kansas | 66219 | — |
| Investigational Site Number US294 | Lafayette | Louisiana | 70508 | — |
| Investigational Site Number US407 | Southfield | Michigan | 48076-5412 | — |
| Investigational Site Number US326 | Omaha | Nebraska | 68134 | — |
| Investigational Site Number US381 | Cincinnati | Ohio | 45246-2316 | — |
| Investigational Site Number US047 | Austin | Texas | 78705-3298 | — |
| Investigational Site Number US073 | Tomball | Texas | 77375 | — |
| Investigational Site Number US391 | Pleasant View | Utah | 84404-4791 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07079670, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07079670 live on ClinicalTrials.gov.